FENNEC PHARMACEUTICALS INC. Adjustments to Additional Paid in Capital, Other
FENNEC PHARMACEUTICALS INC. (FENC) reported Adjustments to Additional Paid in Capital, Other of $18.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-02-14
- FENNEC PHARMACEUTICALS INC. adjustments to additional paid in capital, other for the quarter ending 2018-06-30 was $18.00K.
- FENNEC PHARMACEUTICALS INC. adjustments to additional paid in capital, other for fiscal 2018 was $18.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2018-12-31 | $18.00K 10-K · filed 2020-02-14 | |
| 2018-06-30 | $18.00K 10-Q · filed 2018-11-13 | |
| 2004-06-30 | $18.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |